INTERLEUKIN LEVELS IN THE PATHOGENESIS OF CORONAVIRUS INFECTION (COVID-19) AND THE EFFECT OF A NEW COMBINATION DRUG (G. LUCIDUM AND ALKHADAYA) ON THE COURSE AND PROGNOSIS OF THE DISEASE

Abstract

An outbreak of acute community acquired atypical pneumonia of unknown etiology was reported in Wuhan, the capital of Hubei Province in central China, in December 2019. The pathogen, which turned out to be a new coronavirus, had not previously been detected in human papillomaviruses and was named SARS CoV-2. On March 11, 2020, the WHO recognized the NCI epidemic as a pandemic. SARS-CoV-2 belongs to the genus Betacoronavirus family Coronaviridae .